Published in J Clin Invest on April 01, 1990
Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol (1995) 2.62
Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet (1995) 1.44
The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.29
Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer (1991) 1.12
Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer (1994) 1.02
Abnormal chromosome repair and risk of developing cancer. Environ Health Perspect (1993) 0.97
Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile. J Clin Pathol (1998) 0.92
Immunohistochemical Analysis of the Cell Cycle-Associated Antigens Ki-67 and Retinoblastoma Protein in Parathyroid Carcinomas and Adenomas. Endocr Pathol (1995) 0.91
Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer. J Oncol (2012) 0.90
Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci U S A (1993) 0.89
Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. Am J Pathol (1997) 0.88
Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. Proc Natl Acad Sci U S A (1994) 0.86
Changes in retinoblastoma gene expression during cervical cancer progression. Int J Exp Pathol (2002) 0.81
High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines. Br J Cancer (1996) 0.79
Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma. World J Gastroenterol (2006) 0.77
Reduced expression of the retinoblastoma protein shows that the related signaling pathway is essential for mediating the antineoplastic activity of erufosine. PLoS One (2014) 0.75
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
The p53 proto-oncogene can act as a suppressor of transformation. Cell (1989) 11.67
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57
p53: a frequent target for genetic abnormalities in lung cancer. Science (1989) 7.51
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Hereditary cancer, oncogenes, and antioncogenes. Cancer Res (1985) 5.12
Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 4.54
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (1988) 4.26
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science (1988) 4.15
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (1987) 3.85
Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci U S A (1987) 3.72
Retinoblastoma: clues to human oncogenesis. Science (1984) 3.43
Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37
Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus. Cancer Genet Cytogenet (1984) 3.17
Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child (1978) 3.11
Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med (1989) 3.03
Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science (1988) 2.83
Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology (1984) 2.82
Homozygosity of chromosome 13 in retinoblastoma. N Engl J Med (1984) 2.49
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci U S A (1985) 2.44
Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci U S A (1986) 2.30
Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene (1988) 2.29
The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene (1989) 2.02
Identification of germline and somatic mutations affecting the retinoblastoma gene. Science (1988) 2.00
Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res (1988) 1.70
Non-ocular cancer in relatives of retinoblastoma patients. Br J Cancer (1989) 1.69
Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc Natl Acad Sci U S A (1989) 1.61
A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet (1982) 1.61
Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. Proc Natl Acad Sci U S A (1988) 1.41
The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene (1989) 1.22
RB and the cell cycle: entrance or exit? Cell (1989) 1.18
Nonrandom chromosomal changes in untreated retinoblastomas. Cancer Genet Cytogenet (1983) 1.15
Abnormalities of chromosome #13 in retinoblastomas from individuals with normal constitutional karyotypes. Cancer Genet Cytogenet (1982) 1.12
Studies of the retinoblastoma gene in human sarcomas. Oncogene (1989) 1.08
Complete or partial homozygosity of chromosome 13 in primary retinoblastoma. Cancer Res (1987) 0.89
Resetting central and peripheral circadian oscillators in transgenic rats. Science (2000) 8.63
X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 8.26
The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J (1997) 4.66
An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell (2001) 4.41
A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell (2001) 4.24
Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem (2000) 3.86
Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A (2001) 3.19
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell (2001) 2.97
Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc (2001) 2.30
EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J (1996) 2.11
Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med (1994) 1.97
Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines. Clin Exp Allergy (2001) 1.76
The complete nucleotide sequence of the group II RNA coliphage GA. J Biochem (1986) 1.72
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol (2009) 1.66
Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res (1998) 1.65
Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia (1980) 1.58
B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol (1999) 1.58
Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J Natl Cancer Inst (1995) 1.57
Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet (1997) 1.55
Expression of heat shock protein 70 is altered by age and diet at the level of transcription. Mol Cell Biol (1993) 1.52
Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst (1992) 1.51
X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes. J Biol Chem (2001) 1.49
Multiple brain gas embolism after ingestion of concentrated hydrogen peroxide. Neurology (1997) 1.46
Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oncogene (2008) 1.41
Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine (1991) 1.40
Green fluorescent protein-transgenic rat: a tool for organ transplantation research. Biochem Biophys Res Commun (2001) 1.39
The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol (1994) 1.37
Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res (1997) 1.35
Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res (1994) 1.34
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene (1997) 1.34
The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.29
Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc Natl Acad Sci U S A (1997) 1.25
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. J Clin Oncol (1998) 1.24
Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. J Natl Cancer Inst (1994) 1.24
Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res (1991) 1.23
Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene (1991) 1.23
The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene (1989) 1.22
Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol (2011) 1.19
Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy (2007) 1.19
Age-related alterations in the activation of heat shock transcription factor 1 in rat hepatocytes. Exp Cell Res (2000) 1.19
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res (1994) 1.18
IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol (2001) 1.18
Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology (2001) 1.16
Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res (1999) 1.16
Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis Rheum (1998) 1.15
Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ (2004) 1.15
Effect of formaldehyde on the expression of adhesion molecules in nasal microvascular endothelial cells: the role of formaldehyde in the pathogenesis of sick building syndrome. Clin Exp Allergy (2002) 1.15
A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment. Lung Cancer (2013) 1.14
Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas. Int J Cancer (2000) 1.13
Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest (1992) 1.12
Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy (2002) 1.11
Granzyme release and caspase activation in activated human T-lymphocytes. J Biol Chem (1998) 1.10
Lombard reflex during PAG-induced vocalization in decerebrate cats. Neurosci Res (1997) 1.10
Selective production of transgenic mice using green fluorescent protein as a marker. Nat Biotechnol (1997) 1.09
Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. Proc Natl Acad Sci U S A (1994) 1.08
Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet (1993) 1.08
p53 and RB expression predict progression in T1 bladder cancer. Clin Cancer Res (1998) 1.06
Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer (1993) 1.06
Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Res (1994) 1.06
Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer (1994) 1.05
Retinoblastoma protein inhibits IFN-gamma induced apoptosis. Oncogene (1996) 1.05
Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res (1994) 1.05
Genomic organization of the human retinoblastoma gene. Oncogene (1989) 1.04
Stable operation of a 300-m laser interferometer with sufficient sensitivity to detect gravitational-wave events within our galaxy. Phys Rev Lett (2001) 1.03
Medical assistance at the Brazilian juniors tennis circuit--a one-year prospective study. J Sci Med Sport (2003) 1.02
Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. Cancer Res (1996) 1.02
Use of alternative therapies in older outpatients in the United States and Japan: prevalence, reporting patterns, and perceived effectiveness. J Gerontol A Biol Sci Med Sci (2001) 1.01
Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res (1991) 1.01
Carbonylated proteins in aging and exercise: immunoblot approaches. Mech Ageing Dev (1999) 1.01
Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J Natl Cancer Inst (1994) 1.00
The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer. J Urol (1995) 1.00
An essential role of myosin light-chain kinase in the regulation of agonist- and fluid flow-stimulated Ca2+ influx in endothelial cells. FASEB J (1998) 0.99
Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene (1993) 0.99
Lack of correlation between rare Ha-ras alleles and urothelial cancer in Japan. Int J Cancer (1987) 0.97
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas. Cancer (1996) 0.97
Effect of caloric restriction on the expression of heat shock protein 70 and the activation of heat shock transcription factor 1. Dev Genet (1996) 0.97
Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther (2001) 0.96
Small peripheral lung carcinoma evaluated with incremental dynamic CT: radiologic-pathologic correlation. Radiology (1995) 0.96
Restoration of myelin formation by a single type of myelin basic protein in transgenic shiverer mice. Proc Natl Acad Sci U S A (1989) 0.95
Inhibition of agonist-induced Ca2+ entry in endothelial cells by myosin light-chain kinase inhibitor. Biochem Biophys Res Commun (1996) 0.95
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood (1994) 0.94